Search the Newsreel

Sensus Healthcare Q2 EPS $(0.53) misses estimate; sales fall 69%

Sensus Healthcare reported a significant decline in Q2 2026 revenue, falling 69% year-over-year to $2.3 million, missing analyst estimates. The company's net loss widened to $8.7 million, or $0.53 per share, primarily due to lower unit sales and delayed revenue recognition, along with a …

Sensus Healthcare (NASDAQ:SRTS) Releases Quarterly Earnings Results, Misses Expectations By $0.41 EPS

Sensus Healthcare (NASDAQ:SRTS) announced its quarterly earnings, reporting a significant miss on both EPS and revenue expectations. The company posted a loss of $0.53 per share against an anticipated loss of $0.12, and revenue of $2.29 million, well below the $4.60 million estimate. Despite …

Earnings call transcript: Sensus Healthcare posts Q2 2026 miss, shares fall after hours

Sensus Healthcare reported a significant drop in Q2 revenue to $2.3 million from $7.3 million year-over-year, primarily due to delayed third-party financing for eight equipment units. The company expects to recognize this delayed revenue in Q3, leading to anticipated stronger second-half results. Sensus is …

Sensus Healthcare Inc (SRTS) Faces Challenges in Q2 Earnings: Re

CMS Proposes 26% Increase in Sensus Hospital Delivery Code

Sensus Healthcare (SRTS) announced its Q2 2026 financial results, reporting a decrease in revenue to $2.3 million due to delayed financing approvals for eight units, which will now be recognized in Q3. Despite the revenue dip, the company noted strong commercial execution and a …

Sensus Healthcare Inc expected to post a loss of 9 cents a share - Earnings Preview

Sensus Healthcare Inc (SRTS) is anticipated to report a loss of 9 cents per share for the period ending September 30, 2025, with revenue expected to fall by 28.6% to $6.313 million. Despite the projected loss and revenue decrease, analysts currently rate the shares …

Earnings Preview: SRTS to Report Financial Results Post-market on August 13

This article announces that Sensus Healthcare (SRTS) is expected to report its financial results after market close on August 13. The company is scheduled to host a conference call and webcast on August 14 to discuss these results.

Sensus Healthcare Inc (SRTS) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Sensus Healthcare Inc (SRTS), including its current earnings forecast score of 8.00 and an average price target of $8.00 based on 4 analysts. It details expected revenue for the next quarter at $4.60 million and an anticipated …

Sensus Healthcare Inc (SRTS) Financial Health: Profitability & Balance Sheet Analysis

Sensus Healthcare Inc (SRTS) has a current financial score of 6.52, ranking 148th in the Healthcare Equipment & Supplies industry, indicating robust financial status but low operating efficiency. Its latest quarterly revenue decreased by 59.32% year-over-year to $3.39M, and net profit saw a 2.10% …

Sensus Healthcare Q2 update will stream live Aug. 13 at 4:30 p.m.

Sensus Healthcare, Inc. (Nasdaq: SRTS) will report its second quarter 2026 financial results on Thursday, August 13, 2026. The company will host a conference call and webcast at 4:30 PM Eastern time to discuss the results, provide a business update, and answer questions. Participants …

Sensus Healthcare to Report Second Quarter 2026 Financial Results and Hold Business Update Conference Call on August 13, 2026

Sensus Healthcare, Inc. will announce its second-quarter 2026 financial results on Thursday, August 13, 2026. Following the release, management will host a conference call at 4:30 PM Eastern time to discuss the results, provide a business update, and answer questions. The company focuses on …

Sensus Healthcare updates financial calendar with quarterly results conference call scheduled

Sensus Healthcare has scheduled its second-quarter 2026 financial results release for August 13, 2026. A conference call will be held on the same day at 4:30 p.m. ET to discuss the results, provide a business update, and answer questions. Webcast access will be available …

Sensus Healthcare, Inc. Revenue Breakdown – FWB:5TX

Sensus Healthcare, Inc. (FWB:5TX) generated 23.40 million EUR in revenue last year, with its Radiation Therapy Devices segment being the top performer contributing 18.29 million EUR. The majority of the company's revenue, 21.59 million EUR, originated from the United States. This represents a decrease …

Sensus Healthcare Inc (SRTS) Valuation: PE, PB & Fair Value Analysis

Sensus Healthcare Inc (SRTS) currently has a valuation score of 8.84, placing it 59 out of 199 in the Healthcare Equipment & Supplies industry. Its P/E ratio is -6.19. The company notes that relevant data for P/B, P/S, and P/CF have not yet been …

Sensus Healthcare Inc (SRTS) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Sensus Healthcare Inc (SRTS), detailing its price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 2.71 and is trading between a resistance of 3.14 …

Sensus Healthcare Inc (SRTS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Sensus Healthcare Inc (SRTS), including its major individual and institutional investors. It provides a breakdown of shareholder types, institutional holdings over several quarters, and recent shareholder activity with changes in ownership. The information aims to offer insights …

Sensus Healthcare Inc (SRTS) Cash Flow

This article provides a detailed historical cash flow statement for Sensus Healthcare Inc (SRTS), covering quarterly data since FY2014Q4. It includes operating, investing, and financing cash flows, along with related metrics and year-over-year percentage changes. The report also features a FAQ section explaining key …

Sensus Healthcare Inc (SRTS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Sensus Healthcare Inc (SRTS), categorized by business segments and geographical regions. It shows that Product Revenue constitutes 78.16% of total revenue and Service Revenue makes up 21.84%. Geographically, the United States accounts for the vast majority …

Sensus Healthcare (SRTS) Gains 3% as Stock Tests Resistance Near $3.18 - Relative Volume

SRTS|Sensus Healthcare Inc|Price:3.030|Chg%:+0.090

Sensus Healthcare Inc. (SRTS) closed at $3.030, up 3.06%, with a market cap of $49.88M. The company, which specializes in non-invasive skin cancer and keloid treatments using superficial radiotherapy, shows strong fundamentals despite recent stock market performance and a shift to a net loss. …

Sensus Healthcare (SRTS) Q4 2025 earnings summary

Sensus Healthcare (SRTS) summarized its Q4 2025 earnings, highlighting the achievement of exclusive CPT/CMS reimbursement codes for SRT and IG-SRT, which are expected to support broader adoption of non-invasive skin cancer treatments. The company reported shipments of 14 SRT systems in Q4 2025, reaching …